In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 2, 2007, Pages 305-308

  Sanguinetti, M ^a   Posteraro, B ^a   Romano, L ^b   Battaglia, F ^c   Lopizzo, T ^a   De Carolis, E ^a   Fadda, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

Antifungal susceptibility; Broth microdilution; MIC

Indexed keywords

BERGAMOT OIL; FUROCOUMARIN; GRISEOFULVIN; ITRACONAZOLE; ANTIFUNGAL AGENT; VEGETABLE OIL;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DERMATOPHYTE; DILUTION; DISTILLATION; EPIDERMOPHYTON FLOCCOSUM; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS ISOLATION; GROWTH INHIBITION; GROWTH REGULATION; IN VITRO STUDY; INOCULATION; MICROSPORUM CANIS; MICROSPORUM GYPSEUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS; ARTHRODERMA; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; MICROBIAL SENSITIVITY TESTS; PLANT OILS;

EID: 33947511305     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl473     Document Type: Article

References (26)

1. Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev 1995; 8: 240-59.
2. Jessup CJ, Warner J, Isham N et al. Antifungal susceptibility testing of dermatophytes: Establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol 2000; 38: 341-4.
3. Walsh TJ, Groll AH. Emerging fungal pathogens: Evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis 1999; 1: 247-61.
4. Artis WM, Odle BM, Jones HE. Griseofulvin-resistant dermatophytosis correlates with in vitro resistance. Arch Dermatol 1981; 117: 16-9.
5. Mukherjee PK, Leidichh SD, Isham N et al. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother 2003; 47: 82-6.
6. Favre B, Ghannoum MA, Ryder NS. Biochemical characterization of terbinafine-resistant Trichophyton rubrum isolates. Med Mycol 2004; 42: 525-9.
7. Mondello F, De Bernardis F, Girolamo A et al. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts. J Antimicrob Chemother 2003; 51: 1223-9.
8. Hammer KA, Carson CF, Riley TV. In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. J Antimicrob Chemother 2002; 50: 195-9.
9. Pina-Vaz C, Gonçalves Rodrigues A, Pinto E et al. Antifungal activity of Thymus oils and their major compounds. J Eur Acad Dermatol Venereol 2004; 18: 73-8.
10. Dorman HJ, Deans SG. Antimicrobial agents from plants: Antibacterial activity of plant volatile oils. J Appl Microbiol 2000; 88: 308-16.
11. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999; 12: 564-82.
12. Pizzimenti F, Tulino G, Marino A. Antimicrobial and antifungal activity of bergamot oil. In: Programs and Abstracts of the International Congress: 'Bergamotto 98. Stato dell'arte' Reggio Calabria, Italy, 1998 Abstract no. 38. Laruffa, Regio Calabria, Italy.
13. Verzera A, Trozzi A, Gazea F et al. Effects of rootstock on the composition of bergamot (Citrus bergamia Risso et Poiteau) essential oil. J Agric Food Chem 2003; 5: 206-10.
14. Romano L, Battaglia F, Masucci L et al. In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates. J Antimicrob Chemother 2005; 55: 110-4.
15. Kane J, Summerbell RC. Trichophyton, Microsporum, Epidermophyton, and other agents of superficial mycoses. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolkin RH, eds. Manual of Clinical Microbiology. Washington: ASM Press, 1999; 1275-94.
16. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi: Approved Standard M38-A. NCCLS, Wayne, PA, USA, 2002.
17. Ghannoum MA, Chaturvedi V, Espinel-Ingroff A et al. Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes. J Clin Microbiol 2004; 42 2977-9.
18. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A2. NCCLS, Villanova, PA, USA, 2002.
19. Tejasvi T, Sharma VK, Sethuraman G et al. Invasive dermatophytosis with lymph node involvement in an immunocompetent patient. Clin Exp Dermatol 2005; 30: 506-8.
20. Zapata Garrido AJ, Romo AC, Padilla FB. Terbinafine hepatotoxicity. A case report and review of literature. Ann Hepatol 2003; 2: 47-51.
21. Huang DB, Ostrosky-Zeichner L, Wu JJ et al. Therapy of common superficial fungal infections. Dermatol Ther 2004; 2: 517-22.
22. Gupta AK, Einarson TR, Summerbell RC et al. An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs 1998; 55: 645-74.
23. Kyle AA, Dahl MV. Topical therapy for fungal infections. Am J Clin Dermatol 2004; 5: 443-51.
24. Hammer KA, Carson CF, Riley TV. Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol 1999; 86: 985-90.
25. Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (tea tree) oil: A review of antimicrobial and other medicinal properties. Clin Microbiol Rev 2006; 19: 50-62.
26. Martin KW, Ernst E. Herbal medicines for treatment of fungal infections: a systematic review of controlled clinical trials. Mycoses 2003; 47: 87-92.